| Literature DB >> 32172817 |
Carlos L Manrique-Caballero1, Sadudee Peerapornratana2, Cassandra Formeck3, Gaspar Del Rio-Pertuz1, Hernando Gomez Danies1, John A Kellum4.
Abstract
Hemolytic uremic syndrome is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome have a similar clinical presentation. Diagnostic needs to be prompt to decrease mortality, because identifying the different disorders can help to tailor specific, effective therapies. However, diagnosis is challenging and morbidity and mortality remain high, especially in the critically ill population. Development of clinical prediction scores and rapid diagnostic tests for hemolytic uremic syndrome based on mechanistic knowledge are needed to facilitate early diagnosis and assign timely specific treatments to patients with hemolytic uremic syndrome variants.Entities:
Keywords: Atypical HUS; Complement-mediated HUS; Critically ill; Microangiopathy
Mesh:
Substances:
Year: 2020 PMID: 32172817 DOI: 10.1016/j.ccc.2019.11.004
Source DB: PubMed Journal: Crit Care Clin ISSN: 0749-0704 Impact factor: 3.598